1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsFederal funding for small businesses developing innovative technologies, including blockchain, AI, and quantum, with clear commercialization paths. This program supports feasibility studies for deep tech projects.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: US-incorporated for-profit small businesses (under 500 employees, >50% US-owned); foreign founders willing to incorporate a Delaware C-Corp; deep tech projects with clear commercialization paths; blockchain infrastructu…. Confirm the full requirements in the official notice before applying.
The current listing shows up to $295,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
SBIR Phase I — US Small Business Innovation is funded by Various Federal Agencies (e.g., NSF, DOE, NIH, DARPA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Small Business Transition Grant for New Entrepreneurs (SBIR) — R43 Phase I is a grant from the National Institutes of Health (NIH) that funds early-stage scientific innovation by small businesses aiming to bring biomedical breakthroughs to the commercial marketplace. The Phase I award supports feasibility research, evaluating technical merit and commercial potential of proposed innovations. Eligible applicants are U.S. small business concerns, particularly new entrepreneurs, applying under PAR-24-131. Awards cover up to approximately $306,872 in total costs for Phase I. The most recent deadline is September 5, 2026.
NIH SBIR/STTR Parent SBIR (R43/R44) Clinical Trial Not Allowed (PA-24-245) is sponsored by National Institutes of Health (NIH). The NIH SBIR program supports small businesses developing innovative technologies that address health-related challenges through Phase I and Phase II funding, focusing on establishing technical feasibility, research and development, and advancing toward commercialization.
The FY2026 spending package preserves NIH, NSF, and DOE funding while blocking the 15% indirect cost cap. A detailed breakdown of what passed, what is next in the Senate, and how researchers should position themselves.
Read articleOn July 22, 2026 the White House announced more than $5 billion and 15-plus federal agencies behind the Genesis Mission — a national effort to point AI at the hardest problems in science. Here is what the mission actually funds, how its five National Science and Technology Challenges map to real solicitations already opening, and how a research team or small business should position for the money flowing out of it.
Read articleThe reclassification of federal grant-making employees under Schedule F could politicize billions in research funding decisions. Grant seekers need to understand the stakes and adapt their strategies now.
Read article